Danielle Geyen, PA-C

Danielle Geyen practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Danielle Geyen's NPI, 1508336215, was assigned on November 26, 2018. Danielle Geyen holds Texas license PA12694.

Danielle Geyen's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Danielle Geyen's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Geyen practices. Vendor and product names are available with a free account.

Physician assistant is Danielle Geyen's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Danielle Geyen is licensed in Texas.

CMS data shows 35 Medicare services from Danielle Geyen across 1 procedure code in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $1,428 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Danielle Geyen in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Danielle Geyen's median patient age at 67, with 78% women.

In 2024, Danielle Geyen wrote 110 Medicare Part D claims for 59 patients. 85% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $369 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Danielle Geyen for performance year 2024, reported as part of a group. Danielle Geyen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Danielle Geyen from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,267.